Aker BioMarine held extraordinary shareholder meeting on merger plan

• Aker BioMarine held an extraordinary general meeting on Aug. 17, 2026.
• Shareholders adopted the merger plan for a triangular merger with Aker Capital NewCo as the surviving entity.
• The merger has not closed; completion remains subject to customary closing conditions.
• Merger approval satisfied a condition for Aker Capital’s related cash offer.
• Cash offer settlement is due no later than three trading days following the meeting’s merger approval.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aker BioMarine ASA published the original content used to generate this news brief on August 17, 2026, and is solely responsible for the information contained therein.